Dharmaiah, Vinay Rao, and Jennifer S. Yu


26


HYPERTHERMIA


SHARVARI DHARMAIAH, VINAY RAO, AND JENNIFER S. YU






 





 





Question 1


What is hyperthermia?







Question 2


What are the different methods of local hyperthermia?







Question 3


What are the different methods of regional hyperthermia?







 





Question 1 What is hyperthermia?


Answer 1


Hyperthermia is a form of cancer treatment wherein body tissues are exposed to ablative (50°C–60°C) or fever range (39°C–43°C) temperatures. Hyperthermia improves cancer control through multiple mechanisms including directly damaging or killing cancer cells, increasing perfusion to improve radiation sensitivity and drug delivery, and improving the antitumor immune response. It is most often used alongside other forms of cancer therapy, such as radiation and chemotherapy.


Chu K, Dupuy D. Thermal ablation of tumors: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.







Question 2 What are the different methods of local hyperthermia?


Answer 2


In local hyperthermia, heat is applied to a small area. Based on the location of the tumor, hyperthermia can be administered by external, intraluminal, or interstitial approaches. The external method is used to treat superficial tumors and utilizes external applicators that focus energy on the tumor. Intraluminal or endocavitary methods are typically used within body cavities, for example, for treatment of advanced cervical cancer. Probes are inserted through the cavity into the tumor to deliver direct heat energy. Interstitial applications are used to treat deep tumors. Under anesthesia, a catheter is inserted into the tumor and the heat source is then inserted into the catheter to heat the tumor.


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.


van der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13(8):1173–1184.







Question 3 What are the different methods of regional hyperthermia?


Answer 3


In regional hyperthermia, various methods are used to heat large areas of the body such as a limb, body cavity, or an organ. The different approaches utilized are deep tissue, regional perfusion, or continuous hyperthermic peritoneal perfusion (CHPP) techniques. Deep tissue methods are used to treat tumors within the body where external applicators are positioned around the target organ or cavity and radiofrequency or microwave energy is administered. Regional perfusion is used to treat tumors in the arms and legs or cancers in some internal organs. In this method, which is often combined with chemotherapy, a portion of the patient’s blood is removed, heated, and then perfused through the limb or organ. CHPP is used to treat cancers within the peritoneal cavity. During surgery, the treatment is administered through the use of heated anticancer drugs that flow from a warming device through the peritoneal cavity.


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.


van der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13(8):1173–1184.







 





Question 4


In in vitro models, what is the relationship between temperature and cell death?







Question 5


What are some major factors that differentiate hyperthermia from irradiation treatment?







Question 6


How is the Arrhenius plot useful in assessing the effects of thermal damage in tissues?







 





Question 4 In in vitro models, what is the relationship between temperature and cell death?


Answer 4


In in vitro models, cell death occurs in an exponential pattern that can be modeled with the rate of killing increasing as the temperature increases.


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.







Question 5 What are some major factors that differentiate hyperthermia from irradiation treatment?


Answer 5


  Following radiation treatment, cells frequently die when attempting to undergo mitosis (mitotic cell death). In hyperthermia, heat-induced damage can facilitate necrosis or apoptosis of cells throughout the cell cycle.


  Hyperthermia can impair DNA repair.


  Hyperthermia affects both differentiating and dividing cells.


  Tissue damage is expressed immediately if the temperature is high enough.


  Tissue hypoxia can reduce the sensitivity of cells to radiation but can increase heat-induced damage in hyperthermia.


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.







Question 6 How is the Arrhenius plot useful in assessing the effects of thermal damage in tissues?


Answer 6


The Arrhenius plot serves as a basis for understanding the thermal doses necessary in clinical hyperthermia applications. In an Arrhenius plot, the slope designates the activation energy (Ea) of the chemical process involved in killing cancer cells. Above the “breakpoint,” a temperature point (about 43°C) in which there is a significant change in the slope of the plot, a change in 1°C signifies a doubling of the rate of cell killing. Below this value, the rate of cell death can drop by a factor between 2 and 4 for each degree Celsius drop. Differences in activation energy both below and above this breakpoint may demonstrate different means of cell killing or the development of thermotolerance in some cells.


The Arrhenius equation is described by ln k = ln AEa/RT, where k is the rate constant, T is the temperature in Kelvin, A is a preexponential factor, Ea is the activation energy, and R is the universal gas constant. The y-intercept = ln A and slope = – Ea/R.



Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.







 





Question 7


What is a thermal enhancement ratio (TER)?







Question 8


What are the factors that affect the sensitivity of direct cellular damage due to hyperthermia?







Question 9


What is the therapeutic gain factor?







Question 10


What is the importance of indirect effects of hyperthermia on heat and the tumor microenvironment?







 





Question 7 What is a thermal enhancement ratio (TER)?


Answer 7


TER is the ratio of radiation doses with and without the administration of heat necessary to produce a specific level of biological damage. The TER increases with increasing temperature and can be used to predict effective treatment doses. TER from clinical data ranges from 1.15 to 1.5.


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.







Question 8 What are the factors that affect the sensitivity of direct cellular damage due to hyperthermia?


Answer 8


Factors that improve the sensitivity of cells to direct damage by hyperthermia include:


  An acidic environment


  A hypoxic environment


  A state of nutritional deprivation


  Poor vascularization or an increased distance from capillaries


  Destabilization of cell membrane structure through the use of agents, such as alcohols, that may modify the lipid content within cells


  Dysregulation of the normal cell growth cycle


Hall EJ, Giaccia AJ. Hyperthermia. In: Hall EJ, Giaccia AJ, eds. Radiobiology for the Radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:490–511.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 28, 2017 | Posted by in GENERAL RADIOLOGY | Comments Off on Dharmaiah, Vinay Rao, and Jennifer S. Yu

Full access? Get Clinical Tree

Get Clinical Tree app for offline access